These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25680753)

  • 1. A novel method for analyzing extremely biased agonism at G protein-coupled receptors.
    Stahl EL; Zhou L; Ehlert FJ; Bohn LM
    Mol Pharmacol; 2015 May; 87(5):866-77. PubMed ID: 25680753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
    Lymperopoulos A
    Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
    Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
    ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors.
    DiMattio KM; Ehlert FJ; Liu-Chen LY
    Eur J Pharmacol; 2015 Aug; 761():235-44. PubMed ID: 26057692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window.
    Gillis A; Sreenivasan V; Christie MJ
    Mol Pharmacol; 2020 Oct; 98(4):410-424. PubMed ID: 32665252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noribogaine is a G-protein biased κ-opioid receptor agonist.
    Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
    Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
    Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitating Ligand Bias Using the Competitive Model of Ligand Activity.
    Stahl EL; Ehlert FJ; Bohn LM
    Methods Mol Biol; 2019; 1957():235-247. PubMed ID: 30919358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
    Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
    Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of functionally selective, small molecule agonists at kappa opioid receptors.
    Zhou L; Lovell KM; Frankowski KJ; Slauson SR; Phillips AM; Streicher JM; Stahl E; Schmid CL; Hodder P; Madoux F; Cameron MD; Prisinzano TE; Aubé J; Bohn LM
    J Biol Chem; 2013 Dec; 288(51):36703-16. PubMed ID: 24187130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-coupled Receptor Biased Agonism.
    Hodavance SY; Gareri C; Torok RD; Rockman HA
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):193-202. PubMed ID: 26751266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.
    Ho JH; Stahl EL; Schmid CL; Scarry SM; Aubé J; Bohn LM
    Sci Signal; 2018 Aug; 11(542):. PubMed ID: 30087177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.
    Burgueño J; Pujol M; Monroy X; Roche D; Varela MJ; Merlos M; Giraldo J
    Sci Rep; 2017 Nov; 7(1):15389. PubMed ID: 29133887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Mol Pharmacol; 2015 Aug; 88(2):335-46. PubMed ID: 26013541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
    Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
    Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining efficacy: exploiting functional selectivity for drug discovery.
    Gesty-Palmer D; Luttrell LM
    Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.
    Bridge LJ; Mead J; Frattini E; Winfield I; Ladds G
    J Theor Biol; 2018 Apr; 442():44-65. PubMed ID: 29337260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.